MassHealth, the Massachusetts Medicaid program, will soon bar managed care plans for paying for certain high-cost obesity drugs using 340B.

Massachusetts to Bar Managed Medicaid Payments for GLP-1 Drugs for 340B Patients

Massachusetts will soon change its Medicaid payment policy to bar managed care plans from paying for seven high-cost, anti-obesity medications [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at